Assertio Stock Soars on Revised Garda Merger Offer

Key Merger Developments

Assertio Holdings (NASDAQ:ASRT) shares surged 16% on Monday following the announcement of an amended merger agreement with Garda Therapeutics. The revised deal increases the all-cash tender offer price for Assertio shares to $21.80.

Revised Offer Details

The new offer represents a significant 21.1% premium over Garda's original proposal from April 8, 2026, and a 63.1% premium compared to Assertio's stock price on March 20, 2026. This adjustment values the entire transaction at approximately $153.2 million. The decision to raise the price came after Assertio engaged with multiple parties and received a Superior Proposal during its "window-shop" period. Assertio's Board of Directors has determined that Garda's increased offer is the most favorable outcome for its stockholders.

Market Reaction and Next Steps

Under the amended terms, Garda will acquire all outstanding Assertio shares. The transaction, which does not include a contingent value right, is anticipated to close in the second quarter of 2026, subject to customary closing conditions. Following the successful completion of the tender offer, any remaining shares will be acquired in a second-step merger at the same price. Consequently, Assertio's common stock will be delisted from the Nasdaq stock exchange.

Conclusion

Garda's higher bid has been accepted by Assertio's board, signaling a clear path toward the company's acquisition and privatization. The deal's progression now depends on the tender of a majority of Assertio's outstanding shares and other standard closing conditions.

FAQ

Q: What is the new offer price for Assertio shares?
A: The amended all-cash tender offer price is $21.80 per share.

Q: Why did Garda increase its offer?
A: The offer was increased after Assertio received a Superior Proposal from another party during its strategic review period.

Q: What will happen to Assertio's stock after the acquisition?
A: Upon completion of the merger, Assertio's common stock will no longer be listed or traded on the Nasdaq exchange.

Source: Investing.com